Scarica l'app Stockscreener
56.68
3.54%
1.94
Dopo l'orario di chiusura:
56.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$54.74
Aprire:
$56.35
Volume 24 ore:
2.99M
Relative Volume:
1.30
Capitalizzazione di mercato:
$8.87B
Reddito:
$1.22B
Utile/perdita netta:
$81.07M
Rapporto P/E:
110.25
EPS:
0.5141
Flusso di cassa netto:
$223.02M
1 W Prestazione:
+5.92%
1M Prestazione:
+6.68%
6M Prestazione:
-5.44%
1 anno Prestazione:
+13.82%
Intervallo 1D:
$54.51
$57.01
Intervallo di 1 settimana:
$51.03
$57.01
Portata 52W:
$46.05
$72.16
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
612-379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
56.68 | 8.56B | 1.22B | 81.07M | 223.02M | 0.5141 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne (TECH) executive nets shares from 794 RSU exercise - Stock Titan
Investors brace for Bio-Techne earnings amid muted outlook By Investing.com - Investing.com Canada
Bio-Techne sets 8 a.m. May 6 webcast for fiscal Q3 results - Stock Titan
Bio-Techne CEO Kim Kelderman to speak at BofA healthcare event - Stock Titan
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference - ChartMill
Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 31.36% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
MSN Money - MSN
Vanguard Group Inc. Sells 121,495 Shares of Bio-Techne Corp $TECH - MarketBeat
UBS Group AG Raises Position in Bio-Techne Corp $TECH - MarketBeat
Conestoga Capital Advisors LLC Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Comerica Bank Increases Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MSN
Understanding the Setup: (TECH) and Scalable Risk - Stock Traders Daily
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Vanguard (NASDAQ: TECH) holds 7.38% stake — 11.56M shares reported - Stock Titan
Bio-Techne's Q3 Earnings on Deck: What's in Store for the Stock? - Yahoo Finance
Bio-Techne (TECH) Expected to Announce Earnings on Wednesday - MarketBeat
Is There Now An Opportunity In Bio-Techne (TECH) After Recent Share Price Weakness - simplywall.st
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
M&T Bank Corp Buys 70,496 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Analysis: Exploring a 33% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Impax Asset Management Group plc Invests $11.47 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (TECH) CEO nets shares after stock option exercise - Stock Titan
[Form 4] BIO-TECHNE Corp Insider Trading Activity - Stock Titan
Bio-Techne Corp. Stock Hits Day Low of $51.13 Amid Price Pressure - Markets Mojo
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results - Investing News Network
What to expect from Bio-Techne's Q3 2026 earnings report - msn.com
Bio-Techne (NASDAQ:TECH) Stock Price Down 10.3%Time to Sell? - MarketBeat
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Bio-Techne Corp (TECH) Stock Analysis: Navigating a 22% Potential Upside Amidst Market Dynamics - DirectorsTalk Interviews
Bio-Techne Reorganizes Brand To Link Research Spatial And Diagnostics Workflows - Yahoo Finance
The Technical Signals Behind (TECH) That Institutions Follow - Stock Traders Daily
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know - Yahoo Finance
Arvin Capital Management LP's Bio-Techne Corp(TECH) Holding History - GuruFocus
What to Expect From Bio-Techne's Q3 2026 Earnings Report - Barchart.com
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity - Investing News Network
Bio-Techne (TECH) CEO exercises 36,500 options and uses 32,088 shares for taxes - Stock Titan
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):